Kymera Therapeutics Inc. (KYMR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
57.90
1.90 (3.39%)
At close: Oct 03, 2025, 3:59 PM
56.79
-1.92%
After-hours: Oct 03, 2025, 07:28 PM EDT

Kymera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
120.26M 109.97M 68.39M 47.98M
Short-Term Investments
368.49M 264.92M 338.77M 394.44M
Long-Term Investments
362.16M 61.43M 152.33M 125.19M
Other Long-Term Assets
7.74M 7.93M -122.02M -98.77M
Receivables
947K 18.76M 2.54M 135K
Inventory
n/a n/a -12.25M -8.99M
Other Current Assets
20.58M 11.67M 9.71M n/a
Total Current Assets
510.27M 405.32M 559.49M 567.61M
Property-Plant & Equipment
97.86M 101.08M 13.33M 11.88M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
467.77M 170.44M 43.64M 38.3M
Total Assets
978.03M 575.76M 603.13M 605.9M
Account Payables
5.99M 7.08M 4.33M 4M
Deferred Revenue
13.58M 37.88M 63.26M 101.03M
Short-Term Debt
13.11M n/a 3.94M 3.6M
Other Current Liabilities
21.98M 23.16M 15.71M -3.37M
Total Current Liabilities
67.77M 85.69M 63.26M 101.03M
Long-Term Debt
n/a n/a 13.39M 14.36M
Other Long-Term Liabilities
n/a n/a -13.14M -14.3M
Total Long-Term Liabilities
74.65M 95.1M 49.72M 45.23M
Total Liabilities
142.42M 180.79M 112.98M 146.27M
Total Debt
87.76M 84.67M 17.34M 17.96M
Book Value
835.62M 394.97M 490.15M 459.64M
Book Value Per Share
11.14 6.77 9.09 9.58
Common Stock
7K 6K 6K 5K
Retained Earnings
-754.61M -530.75M -383.79M -228.98M
Comprehensive Income
-1.49M -552K -4.95M -660K
Shareholders Equity
835.62M 394.97M 490.15M 459.64M
Total Investments
730.65M 326.35M 491.1M 519.63M